Avastin for Post-photocoagulation Macular Edema

Sponsor
Asociación para Evitar la Ceguera en México
Study ID
NCT00801866
Phase
PHASE4
Status
Withdrawn

Conditions

  • Macular Edema

Eligibility Criteria

Sex
ALL
Age
15 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Bevacizumab — DRUG
    Intravitreal administration
  • Panretinal Photocoagulation — PROCEDURE
    Panretinal Photocoagulation

Study Details

to evaluate the efficacy of a single intravitreal bevacizumab (IVB) injection, 0.1mL (2.5mg), against panretinal photocoagulation (PRP)-induced macular thickening and visual disturbance in patients with severe nonproliferative diabetic retinopathy (NPDR) and proliferative diabetic retinopathy (PDR) and good vision

Key Dates

First listed
Dec 4, 2008
Start date
Dec 31, 2008
Status verified
May 2024
Primary completion
Dec 31, 2008
Completion
Dec 31, 2008

Study Design

Enrollment
0 participants (actual)
Primary purpose
TREATMENT

Arms

  • Experimental: Group 1
    Panretinal Photocoagulation + Bevacizumab
  • Experimental: Group 2
    Panretinal Photocoagulation

Primary Outcome Measure

Best Corrected Visual Acuity

Related Studies